We read with interest the article on ifosfamide-induced hyperpigmentation by Teresi et al.' In our experience, this is a widespread, if underreported phenomenon. In Newcastle, United Kingdom, children with nonmetastatic soft tissue sarcomas are initially treated with five courses of ifosfamide (IF)
Ifosfamide-induced hyperpigmentation
β Scribed by Mary E. Teresi; Daryl J. Murry; Albert S. Cornelius
- Publisher
- John Wiley and Sons
- Year
- 1993
- Tongue
- English
- Weight
- 280 KB
- Volume
- 71
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract We describe 2 cases of proximal tubular defects induced by the administration of ifosfamide at a dosage of 6 g/m^2^/course over 2 days in children with a diagnosis of malignant mesenchymal tumors. This adverse effect could be minimized dividing dosage of the drug. However at present it
## BACKGROUND. The spectrum of side effects induced by chemotherapy includes skin hyperpigmentation. This is prone to occur following treatment with alkylating agents and doxorubicin. More recently, hyperpigmentation was discovered in patients treated exclusively with intra-arterial cisplatin and
## Background and objective: Cutaneous hyperpigmentations are well-documented, but nevertheless rare side-effects of high-dose or long-term minocycline therapy. the pigmental changes, may last for years, even though therapy has been abrogated. to date, no safe and effective therapy has been describ